Our partnerships enable high quality respiratory research across disease areas and allow translation back into patient care.

We are part of several major national/international collaborations and work closely with commercial pharmaceutical companies including Glaxosmithkline (GSK) and AstraZeneca. 

We have close links on respiratory themes with researchers within other research groupings in the University of Nottingham and Nottingham University Hospitals NHS Trust, such as epidemiology, molecular microbiology, drug discovery, allergy, immunology and child health.

We are part of several major national/international collaborations and work closely with commercial pharma companies and are part of the NIHR NOCRI Translational Research Collaboration (TRC) in inflammatory respiratory disease headed by Professor Dominick Shaw in Nottingham.